Header Logo

Connection

ALASTAIR THOMPSON to Aromatase Inhibitors

Back to Details
This is a "connection" page, showing publications ALASTAIR THOMPSON has written about Aromatase Inhibitors.
ALASTAIR THOMPSON
Connection Strength
0.686
Aromatase Inhibitors
  1. Importance of long-term follow-up of women receiving adjuvant therapy for breast cancer in the community. J Clin Oncol. 2011 Sep 01; 29(25):3492; author reply 3492; discussion 3492-3.
    View in: PubMed
    Score: 0.336
  2. Neoadjuvant treatment of breast cancer. Ann Oncol. 2012 Sep; 23 Suppl 10:x231-6.
    View in: PubMed
    Score: 0.091
  3. Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer. Br J Cancer. 2012 May 08; 106(10):1618-25.
    View in: PubMed
    Score: 0.089
  4. The importance of nonpharmacogenetic factors in endocrine therapy. Pharmacogenomics. 2012 Apr; 13(6):721-8.
    View in: PubMed
    Score: 0.088
  5. Breast cancer (non-metastatic). Clin Evid. 2006 Jun; (15):2360-92.
    View in: PubMed
    Score: 0.059
  6. Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer. 2013 Apr 16; 108(7):1515-24.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.